Related Experiment Video
Updated: Feb 5, 2026
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
2.1K
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
Rupert Bartsch1, Elisabeth Bergen1
1Department of Medicine 1, Clinical Division of Oncology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Memo
|September 18, 2018
Summary
This review highlights 2017 San Antonio Breast Cancer Symposium findings on chemotherapy, targeted therapy, and immunotherapy. It covers adjuvant chemotherapy, HER2-positive and triple-negative breast cancer treatments, and immunotherapy advancements.
Area of Science:
- Oncology
- Clinical Trials
- Breast Cancer Research
Background:
- The 2017 San Antonio Breast Cancer Symposium (SABCS) presented significant clinical data.
- Advances in breast cancer treatment include chemotherapy, targeted therapy, and immunotherapy.
Purpose of the Study:
- To review key findings from the 2017 SABCS.
- To focus on adjuvant chemotherapy, targeted therapies for specific breast cancer subtypes, and immunotherapy.
- To provide an update on the latest developments in breast cancer treatment modalities.
Main Methods:
- Review of presented data at the 2017 SABCS.
- Focus on studies related to dose-dense and/or sequential adjuvant chemotherapy.
- Analysis of updates on targeted therapies for HER2-positive and triple-negative breast cancer.
- Summary of new immunotherapy results.
Main Results:
- Significant data on dose-dense and sequential adjuvant chemotherapy were presented.
- Updates on targeted therapies for HER2-positive breast cancer were discussed.
- New findings regarding targeted therapies for triple-negative breast cancer were shared.
- Emerging results in the field of breast cancer immunotherapy were summarized.
Conclusions:
- The 2017 SABCS showcased important advancements across chemotherapy, targeted therapy, and immunotherapy.
- Adjuvant chemotherapy strategies continue to evolve.
- Targeted therapies show promise for specific breast cancer subtypes.
- Immunotherapy represents a rapidly developing area in breast cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
01:27Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
784
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
784
01:26Group Therapy
446
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
446
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
887
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
887